Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of PCSK9 inhibitors in cardiovascular diseases: a systematic review.
Azari, Samad; Rezapour, Aziz; Omidi, Negar; Alipour, Vahid; Behzadifar, Masoud; Safari, Hossein; Tajdini, Masih; Bragazzi, Nicola Luigi.
Afiliación
  • Azari S; Department of Health Economics, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
  • Rezapour A; Health Management and Economics Research Center, School of Health Management and Information Sciences, Iran University of Medical Sciences, Rashid Yasemi Street, Upper than Mirdamad St, Tehran, Iran. rezapour.a@iums.ac.ir.
  • Omidi N; Department of Cardiology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Alipour V; Health Management and Economics Research Center, School of Health Management and Information Sciences, Iran University of Medical Sciences, Rashid Yasemi Street, Upper than Mirdamad St, Tehran, Iran.
  • Behzadifar M; Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
  • Safari H; Health Management and Economics Research Center, School of Health Management and Information Sciences, Iran University of Medical Sciences, Rashid Yasemi Street, Upper than Mirdamad St, Tehran, Iran.
  • Tajdini M; Department of Cardiology, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Bragazzi NL; School of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Heart Fail Rev ; 25(6): 1077-1088, 2020 11.
Article en En | MEDLINE | ID: mdl-31832834

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Años de Vida Ajustados por Calidad de Vida / Inhibidores de PCSK9 Tipo de estudio: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Heart Fail Rev Asunto de la revista: CARDIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Irán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Años de Vida Ajustados por Calidad de Vida / Inhibidores de PCSK9 Tipo de estudio: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Heart Fail Rev Asunto de la revista: CARDIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Irán